Local Institution - 0246

Santiago, Santiago Metropolitan 7710007

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, Hepatocellular Carcinoma, Liver Cancer

Studies at this site

• A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation — Running, not enrolling
• A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney — Completed